A critical appraisal of the state of the prescription medications in the United States ...

Far removed from the negative attention such drugs used to get, the hope is that they help people find answers within ...

many with no approved treatments. It has previously suggested that the drug could eventually become a $5 billion-a-year product which, if achieved, would help it weather the impact of patent ...

The approval follows positive results for Fabhalta in the phase 3 APPEAR-C3G study, on which patients with C3G treated with the drug on top of supportive care experienced clinically meaningful ...

Shuttle-based therapies are under active development for an array of brain conditions. “It’s now abundantly clear that we can ...

The novel PDE10A inhibitor CPL'36 offers a new mechanism of action and is both safe and effective for acute exacerbations of schizophrenia, new research suggests.

The opioid crisis has made it even more urgent to come up with novel approaches to treating suffering. Finally there’s ...

There are over 20,000 prescription drugs approved by the Food and Drug Administration (FDA). The number of medical ...

Gilgamesh managed to overcome the issue of functional unblinding in the study, an obstacle experienced by the psychedelic ...